Avenue Therapeutics Inc. (ATXI) stock plunged during pre-market trading. What’s behind this?
Avenue Therapeutics Inc. (NASDAQ: ATXI) stock declined by 28.27% at last close while the ATXI stock price falls during pre-market as well, by 8.94%. Avenue Therapeutics is a pharmaceutical firm whose objective is to produce IV tramadol for patients diagnosed with severe pain in the United States as a viable alternative to conventional opioids. Avenue […]
